Vasoinhibins prevent bradykinin-stimulated endothelial cell proliferation by inactivating eNOS via reduction of both intracellular Ca2+ levels and eNOS phosphorylation at ser1179

Pharmaceuticals

Volumn 4, Issue 7, 2011, Pages 1052-1069

  Thebault, Stéphanie ^a   González, Carmen ^a   García, Celina ^a   Zamarripa, David Arredondo ^a   Nava, Gabriel ^a   Vaca, Luis ^b   López Casillas, Fernando ^a   de la Escalera, Gonzalo Martínez ^a   Clapp, Carmen ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

16kDa prolactin; Bradykinin; Calcium mobilization; Endothelial nitric oxide synthase; Transient receptor potential channels; Vasoinhibins

Indexed keywords

ANGIOGENESIS INHIBITOR; BRADYKININ; CALCIUM ION; CALMODULIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INOSITOL 1,4,5 TRISPHOSPHATE; LANTHANUM; MESSENGER RNA; NITRIC OXIDE; PHOSPHOLIPASE C; SERINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; UNCLASSIFIED DRUG; VASOINHIBIN;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL PROLIFERATION; CELL STIMULATION; CHANNEL GATING; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; INHIBITION KINETICS; NONHUMAN; PROTEIN PROCESSING; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 80051625577     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph4071052     Document Type: Article

References (53)

1. Clapp, C.; Thebault, S.; Arnold, E.; Garcia, C.; Rivera, J.C.; de la Escalera, G.M. Vasoinhibins: Novel inhibitors of ocular angiogenesis. Am. J. Physiol. Endocrinol Metab. 2008, 295, E772-E778.
2. Aranda, J.; Rivera, J.C.; Jeziorski, M.C.; Riesgo-Escovar, J.; Nava, G.; Lopez-Barrera, F.; Quiroz-Mercado, H.; Berger, P.; Martinez de la Escalera, G.; Clapp, C. Prolactins are natural inhibitors of angiogenesis in the retina. Invest. Ophthalmol. Vis. Sci.2005, 46, 2947-2953.
3. Arnold, E.; Rivera, J.C.; Thebault, S.; Moreno-Paramo, D.; Quiroz-Mercado, H.; Quintanar-Stephano, A.; Binart, N.; de la Escalera, G.M.; Clapp, C. High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. Diabetes 2010, 59, 3192-3197.
4. Triebel, J.; Huefner, M.; Ramadori, G. Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy. Eur. J. Endocrinol. 2009, 161, 345-353.
5. Garcia, C.; Aranda, J.; Arnold, E.; Thebault, S.; Macotela, Y.; Lopez-Casillas, F.; Mendoza, V.; Quiroz-Mercado, H.; Hernandez-Montiel, H.L.; Lin, S.H.; et al. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J. Clin. Invest. 2008, 118, 2291-2300.
6. Clapp, C.; Thebault, S.; Jeziorski, M.C.; Martinez de la Escalera, G. Peptide hormone regulation of angiogenesis. Physiol. Rev. 2009, 89, 1177-1215.
7. Silva, P.S.; Cavallerano, J.D.; Sun, J.K.; Aiello, L.M.; Aiello, L.P. Effect of systemic medications on onset and progression of diabetic retinopathy. Nat. Rev. Endocrinol. 2010, 6, 494-508.
8. Pruneau, D.; Belichard, P.; Sahel, J.A.; Combal, J.P. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. Curr. Opin. Invest. Drugs 2010, 11, 507-514.
9. Abdouh, M.; Talbot, S.; Couture, R.; Hassessian, H.M. Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors. Br. J. Pharmacol. 2008, 154, 136-143.
10. Phipps, J.A.; Clermont, A.C.; Sinha, S.; Chilcote, T.J.; Bursell, S.E.; Feener, E.P. Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension 2009, 53, 175-181.
11. Gao, B.B.; Clermont, A.; Rook, S.; Fonda, S.J.; Srinivasan, V.J.; Wojtkowski, M.; Fujimoto, J.G.; Avery, R.L.; Arrigg, P.G.; Bursell, S.E.; et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 2007, 13, 181-188.
12. Miura, S.; Matsuo, Y.; Saku, K. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 2003, 41, 1118-1123.
13. Morbidelli, L.; Parenti, A.; Giovannelli, L.; Granger, H.J.; Ledda, F.; Ziche, M. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br. J. Pharmacol. 1998, 124, 1286-1292.
14. Gonzalez, C.; Corbacho, A.M.; Eiserich, J.P.; Garcia, C.; Lopez-Barrera, F.; Morales- Tlalpan, V.; Barajas-Espinosa, A.; Diaz-Munoz, M.; Rubio, R.; Lin, S.H.; et al. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 2004, 145, 5714-5722.
15. Michel, T.; Vanhoutte, P.M. Cellular signaling and NO production. Pflügers Arch. Eur. J. Physiol. 2010, 459, 807-816.
16. Balla, T. Regulation of Ca2+ entry by inositol lipids in mammalian cells by multiple mechanisms. Cell.Calcium 2009, 45, 527-534.
17. Putney, J.W. Capacitative calcium entry: From concept to molecules. Immunol. Rev. 2009, 231, 10-22.
18. Rohacs, T. Teaching resources. TRP channels. Sci. STKE 2005, 2005, tr14.
19. Ahmmed, G.U.; Malik, A.B. Functional role of TRPC channels in the regulation of endothelial permeability. Pflügers Arch. Eur. J. Physiol. 2005, 451, 131-142.
20. Schaefer, M.; Plant, T.D.; Obukhov, A.G.; Hofmann, T.; Gudermann, T.; Schultz, G. Receptor-mediated regulation of the nonselective cation channels TRPC4 and TRPC5. J. Biol. Chem. 2000, 275, 17517-17526.
21. Leung, P.C.; Cheng, K.T.; Liu, C.; Cheung, W.T.; Kwan, H.Y.; Lau, K.L.; Huang, Y.; Yao, X. Mechanism of non-capacitative Ca2+ influx in response to bradykinin in vascular endothelial cells. J. Vasc. Res. 2006, 43, 367-376.
22. Bae, S.W.; Kim, H.S.; Cha, Y.N.; Park, Y.S.; Jo, S.A.; Jo, I. Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem. Biophys. Res. Commun. 2003, 306, 981-987.
23. McCabe, T.J.; Fulton, D.; Roman, L.J.; Sessa, W.C. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J. Biol. Chem. 2000, 275, 6123-6128.
24. Tran, Q.K.; Leonard, J.; Black, D.J.; Nadeau, O.W.; Boulatnikov, I.G.; Persechini, A. Effects of combined phosphorylation at Ser-617 and Ser-1179 in endothelial nitric-oxide synthase on EC50(Ca2+) values for calmodulin binding and enzyme activation. J. Biol. Chem. 2009, 284, 11892-11899.
25. Galfione, M.; Luo, W.; Kim, J.; Hawke, D.; Kobayashi, R.; Clapp, C.; Yu-Lee, L.Y.; Lin, S.H. Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr. Purif. 2003, 28, 252-258.
26. Cajero-Juarez, M.; Avila, B.; Ochoa, A.; Garrido-Guerrero, E.; Varela-Echavarria, A.; Martinez de la Escalera, G.; Clapp, C. Immortalization of bovine umbilical vein endothelial cells: A model for the study of vascular endothelium. Eur. J. Cell Biol. 2002, 81, 1-8.
27. Merritt, J.E.; Armstrong, W.P.; Benham, C.D.; Hallam, T.J.; Jacob, R.; Jaxa-Chamiec, A.; Leigh, B.K.; McCarthy, S.A.; Moores, K.E.; Rink, T.J. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J. 1990, 271, 515-522.
28. Ramsey, I.S.; Delling, M.; Clapham, D.E. An introduction to TRP channels. Annu. Rev. Physiol. 2006, 68, 619-647.
29. Hofmann, S.L.; Majerus, P.W. Identification and properties of two distinct phosphatidylinositol-specific phospholipase C enzymes from sheep seminal vesicular glands. J. Biol. Chem. 1982, 257, 6461-6469.
30. Challiss, R.A.; Batty, I.H.; Nahorski, S.R. Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization. Biochem. Biophys. Res. Commun. 1988, 157, 684-691.
31. Grynkiewicz, G.; Poenie, M.; Tsien, R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260, 3440-34450.
32. Clapp, C.; Weiner, R.I. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology 1992, 130, 1380-1386.
33. Parekh, A.B.; Putney, J.W., Jr. Store-operated calcium channels. Physiol. Rev. 2005, 85, 757-810.
34. Vaca, L.; Kunze, D.L. IP3-activated Ca2+ channels in the plasma membrane of cultured vascular endothelial cells. Am. J. Physiol. 1995, 269, C733-C738.
35. Luckhoff, A.; Clapham, D.E. Inositol 1,3,4,5-tetrakisphosphate activates an endothelial Ca(2+)-permeable channel. Nature 1992, 355, 356-358.
36. Huang, S.C.; Chien, C.; Hsiao, L.; Wang, C.; Chiu, C.; Liang, K.; Yang, C. Mechanisms of bradykinin-mediated Ca(2+) signalling in canine cultured corneal epithelial cells. Cell. Signal. 2001, 13, 565-574.
37. Kamouchi, M.; Philipp, S.; Flockerzi, V.; Wissenbach, U.; Mamin, A.; Raeymaekers, L.; Eggermont, J.; Droogmans, G.; Nilius, B. Properties of heterologously expressed hTRP3 channels in bovine pulmonary artery endothelial cells. J. Physiol. 1999, 518, 345-358.
38. Nilius, B.; Droogmans, G. Ion channels and their functional role in vascular endothelium. Physiol. Rev. 2001, 81, 1415-1459.
39. Putney, J.W., Jr. Pharmacology of capacitative calcium entry. Mol. Interv. 2001, 1, 84-94.
40. Clapham, D.E.; Julius, D.; Montell, C.; Schultz, G. International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels. Pharmacol. Rev. 2005, 57, 427-450.
41. Strubing, C.; Krapivinsky, G.; Krapivinsky, L.; Clapham, D.E. TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 2001, 29, 645-655.
42. Okada, T.; Shimizu, S.; Wakamori, M.; Maeda, A.; Kurosaki, T.; Takada, N.; Imoto, K.; Mori, Y. Molecular cloning and functional characterization of a novel receptor-activated TRP Ca2+ channel from mouse brain. J. Biol. Chem. 1998, 273, 10279-10287.
43. Dietrich, A.; Mederos, Y.S.M.; Gollasch, M.; Gross, V.; Storch, U.; Dubrovska, G.; Obst, M.; Yildirim, E.; Salanova, B.; Kalwa, H.; et al. Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol. Cell. Biol. 2005, 25, 6980-6989.
44. Wong, C.O.; Sukumar, P.; Beech, D.J.; Yao, X. Nitric oxide lacks direct effect on TRPC5 channels but suppresses endogenous TRPC5-containing channels in endothelial cells. Pflügers Arch. Eur. J. Physiol. 2010, 460, 121-130.
45. Yoshida, T.; Inoue, R.; Morii, T.; Takahashi, N.; Yamamoto, S.; Hara, Y.; Tominaga, M.; Shimizu, S.; Sato, Y.; Mori, Y. Nitric oxide activates TRP channels by cysteine S-nitrosylation. Nat. Chem. Biol. 2006, 2, 596-607.
46. Yamamoto, S.; Takahashi, N.; Mori, Y. Chemical physiology of oxidative stress-activated TRPM2 and TRPC5 channels. Prog. Biophys. Mol. Biol. 2010, 103, 18-27.
47. Yogi, A.; Callera, G.E.; Antunes, T.T.; Tostes, R.C.; Touyz, R.M. Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. Circ. J. 75, 237-245.
48. Inoue, K.; Xiong, Z.G. Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway. Cardiovasc. Res. 2009, 83, 547-557.
49. Atochin, D.N.; Wang, A.; Liu, V.W.; Critchlow, J.D.; Dantas, A.P.; Looft-Wilson, R.; Murata, T.; Salomone, S.; Shin, H.K.; Ayata, C.; et al. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J. Clin. Invest. 2007, 117, 1961-1967.
50. Walford, G.; Loscalzo, J. Nitric oxide in vascular biology. J. Thromb. Haemostasis 2003, 1, 2112-2118.
51. Boudreau, R.T.; Hoskin, D.W. The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: Lessons from the mast cell model system. Int. Immunopharmacol. 2005, 5, 1507-1518.
52. Duenas, Z.; Rivera, J.C.; Quiroz-Mercado, H.; Aranda, J.; Macotela, Y.; Montes de Oca, P.; Lopez-Barrera, F.; Nava, G.; Guerrero, J.L.; Suarez, A.; et al. Prolactin in eyes of patients with retinopathy of prematurity: implications for vascular regression. Invest. Ophthalmol. Vis. Sci. 2004, 45, 2049-2055.
53. Pan, H.; Nguyen, N.Q.; Yoshida, H.; Bentzien, F.; Shaw, L.C.; Rentier-Delrue, F.; Martial, J.A.; Weiner, R.; Struman, I.; Grant, M.B. Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice. Invest. Ophthalmol. Vis. Sci.2004, 45, 2413-2419.